C

CuraSen Therapeutics, Inc.

15 employees

CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases

Basic info

Industry

biotechnology research

Sectors

Locus Coeruleus
Cerebral Blood Flow
Medical Device
Biotechnology
Neurometabolism
Alzheimer’s Disease
Neurodegeneration
Therapeutics
Parkinson’s Disease
Neuroinflammation

Date founded

2017

Funding rounds raised

Total raised

$55M

from 6 investors over 6 rounds

C

CuraSen Therapeutics, Inc. raised $55M on October 17, 2018

Investors: Chiesi Ventures, Pappas Capital, Alta Partners, Tekla Capital Management, Longitude Capital and New Leaf Venture Partners

FAQ